Werbrouck B MD SPRL
Werbrouck B MD reported total assets of 854,960 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of Werbrouck B MD shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -56 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Werbrouck B MD's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 315,556 € | ||||
| Equity | 226,986 € | ||||
| Cash | 72,762 € | ||||
| EBITDA | 418,622 € | ||||
| Total assets | 854,960 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Werbrouck B MD's financial analysis
- Solvency26.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Werbrouck B MD
Werbrouck B MD's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0633.893.119
- VAT number
- BE0633893119
- Peppol
- Registered · 0208:0633893119 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 16 Jul 2015
- Registered office
- 8900 Ypres
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Werbrouck B MD (SPRL) has been based in Ypres since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 315,556 € and equity of 226,986 €; its revenue is not published. Its solvency stands at 26.5%, below the median of its sector (72.2%).
Companies similar to Werbrouck B MD
Companies in the same business, of comparable size and area, outside its group.
- Docteur Cyrille Degauque Medical specialists activities Verviers · balance sheet 143,682 €
- Geriaters AZ Delta Medical specialists activities Roeselare · balance sheet €1.10m
- Artsen Radiologie AZ Delta Medical specialists activities Roeselare · balance sheet €4.35m
- MDL-AZ Delta Medical specialists activities Roeselare · balance sheet €3.07m
- GynART Medical specialists activities Aartselaar · balance sheet 848,766 €
- Nicolas Massager SRL Medical specialists activities Fontaine-l'Évêque · balance sheet 865,806 €
- DR. Valérie Bertrand Medical specialists activities Hasselt · balance sheet 867,944 €
- dr. Velghe David anesthesie – dr. Veerle D’hondt plastische chirurgie Medical specialists activities Bonheiden · balance sheet 873,440 €
Frequently asked questions about Werbrouck B MD
What is the revenue of Werbrouck B MD?
Werbrouck B MD files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Werbrouck B MD?
In Belgium, the VAT number is the company number prefixed with BE: BE0633893119 for Werbrouck B MD, if the company is VAT-registered. Its company number (CBE) is 0633.893.119.
Where is the registered office of Werbrouck B MD?
According to the CBE register, the registered office of Werbrouck B MD is in 8900 Ypres.
What is the equity of Werbrouck B MD?
At the close of the 2025 financial year, the equity of Werbrouck B MD amounts to 226,986 €, a solvency of 26.5% of total assets.
Who manages Werbrouck B MD?
The register lists 1 active mandates at Werbrouck B MD. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Werbrouck B MD
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →